United States · Bill · HR
H.R. 2557 (115th)
Prostate Cancer Misdiagnosis Elimination Act of 2017
Introduced
19 May 2017
Last action
—
Status
Placed on the Union Calendar, Calendar No. 331.
Sponsors
—
Subjects
Discovery layer
Source updated
5 December 2025
Summary
Prostate Cancer Misdiagnosis Elimination Act of 2017 This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
6 official files
Reported in House (text)
Reported in House (text)
Reported in House · EN · 6 December 2017
Reported in House (PDF)
Reported in House · EN · 6 December 2017
Reported to House amended, Part I
summary · EN · 6 December 2017
Introduced in House (text)
Introduced in House · EN · 19 May 2017
Introduced in House (PDF)
Introduced in House · EN · 19 May 2017
Introduced in House
summary · EN · 19 May 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/house-bill/2557
- Open data entity: https://api.congress.gov/v3/bill/115/hr/2557